Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials.
Bongartz, T
Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials. [electronic resource] - Annals of the rheumatic diseases Jul 2009 - 1177-83 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
1468-2060
10.1136/ard.2008.094904 doi
Antirheumatic Agents--adverse effects
Arthritis, Rheumatoid--drug therapy
Etanercept
Humans
Immunoglobulin G--adverse effects
Neoplasms--chemically induced
Randomized Controlled Trials as Topic
Receptors, Tumor Necrosis Factor
Risk Assessment
Risk Factors
Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials. [electronic resource] - Annals of the rheumatic diseases Jul 2009 - 1177-83 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
1468-2060
10.1136/ard.2008.094904 doi
Antirheumatic Agents--adverse effects
Arthritis, Rheumatoid--drug therapy
Etanercept
Humans
Immunoglobulin G--adverse effects
Neoplasms--chemically induced
Randomized Controlled Trials as Topic
Receptors, Tumor Necrosis Factor
Risk Assessment
Risk Factors